Catalent Inc.

63.48
0.00 (0.00%)
At close: Dec 17, 2024, 9:00 PM

Catalent Revenue Breakdown

Period Ending Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021 Dec 31, 2020 Sep 30, 2020 Jun 30, 2020 Mar 31, 2020 Dec 31, 2019 Sep 30, 2019 Jun 30, 2019 Mar 31, 2019 Dec 31, 2018 Sep 30, 2018
Biologics Revenue 461M 605M 461M 438M 448M 475M 580M 523M 667M 698M 638M 546M 603.3M 543.7M 403.9M 377.1M 357.8M 250M 225.2M 188.6M 231.1M 172.1M 184.3M 154.6M
Biologics Revenue Growth -23.80% +31.24% +5.25% -2.23% -5.68% -18.10% +10.90% -21.59% -4.44% +9.40% +16.85% -9.50% +10.96% +34.61% +7.11% +5.39% +43.12% +11.01% +19.41% -18.39% +34.28% -6.62% +19.21% n/a
PharmaConsumerHealth Revenue 563M 697M 613M 587M 534M 563M 570M 499M n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
PharmaConsumerHealth Revenue Growth -19.23% +13.70% +4.43% +9.93% -5.15% -1.23% +14.23% n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a

Revenue by Geography

Period Ending Jun 30, 2024 Jun 30, 2022 Jun 30, 2021 Jun 30, 2020 Jun 30, 2019 Jun 30, 2018 Jun 30, 2017 Jun 30, 2016 Jun 30, 2015 Jun 30, 2014
Europe Revenue 1.36B 1.51B 1.34B 976.1M 842.1M 897.8M 797.4M 733.2M 795.4M 888.8M
Europe Revenue Growth -9.76% +12.14% +37.59% +15.91% -6.20% +12.59% +8.76% -7.82% -10.51% n/a
United States Revenue 2.82B 3.11B 2.46B n/a n/a 1.22B 996.4M 858.6M 799.3M 682.3M
United States Revenue Growth -9.23% +26.32% n/a n/a n/a +22.42% +16.05% +7.42% +17.15% n/a